Zonisamide for Fibromyalgia & Migraine

University of Pittsburgh

Status and phase: Withdrawn; Phase 4

Conditions: Fibromyalgia; Migraine

Treatments: Drug: zonisamide

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT00259636

EISAI 51-345-749

Details and patient eligibility

About

Patients with fibromyalgia & migraine are randomized to receive zonisamide or placebo.

Full description

Study was not conducted due to logistical problems

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18-65 with fibromyalgia & migraine

Exclusion criteria

• allergy sulfa, liver or kidney disease, pregnant or not using contraception

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind